Immunome IMNM Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.84M+23.0% | -$69.9M-21.7% | -$57.46M-32.4% | -$43.4M-4.2% | -$41.64M+48.1% | ||
| $603K-4.1% | $629K+6.8% | $589K-7.5% | $637K+4.3% | $611K+35.8% | ||
| $7.95M+0.8% | $7.89M+17.0% | $6.75M+26.2% | $5.35M-6.2% | $5.7M+4.3% | ||
| -$58.64M-22.3% | -$47.95M-18.4% | -$40.51M+18.0% | -$49.4M+6.9% | -$53.06M-26.1% | ||
| $3M-24.9% | $4M+258% | $1.12M+23.3% | $905K-75.3% | $3.67M+225% | ||
| —— | —— | —— | —— | —— | ||
| -$12.02M— | $0-100% | $123.88M+293% | -$64.17M-1,361% | $5.09M— | ||
| -$135K-100% | $432.8M+854% | $45.39M— | $0-100% | $162.23M+708% | ||
| -$70.79M-119% | $380.84M+196% | $128.76M— | —— | $114.26M— | ||
| -$61.64M-18.6% | -$51.95M-24.8% | -$41.63M+17.3% | -$50.31M+11.3% | -$56.72M-31.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Immunome's cash flow data come from?
- Every line is extracted from Immunome's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.